M(
Therapeutic Areas
Senex Biotechnology Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Senexin Program (Lead) | Prostate Cancer, Breast Cancer, Leukemia (treatment-resistant/metastatic) | Pre-clinical |
| Undisclosed Program 2 | Cancer | Discovery |
| Undisclosed Program 3 | Cancer | Discovery |
Leadership Team at Senex Biotechnology
IB
Igor B Roninson
Founder, President, Chief Scientific Officer, Chairman
DG
Dennis Goldberg
Chief Executive Officer, Director
GW
George Wilding
Chief Medical Officer
KG
Karthik Gopalakrishnan
Consultant, Corporate & Business Development